Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2/3 1Phase 1 1

Status

Completed 3Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

CNS 1Breast 1

Conditions

Multiple Sclerosis 1Lymphopenia 1Glioblastoma 1Breast Neoplasms 1Astrocytoma 1

Interventions

Cyclophosphamide 1488Cisplatin 1410Paclitaxel 1316Radiotherapy 1259Carboplatin 1247Gemcitabine 1214Docetaxel 1110Bevacizumab 1029Fluorouracil 894Doxorubicin 786Dexamethasone 746Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 673Etoposide 673Irinotecan 634Filgrastim 621Cytarabine 584Leucovorin 578Nivolumab 557Vincristine 510Prednisone 474Cetuximab 464Bortezomib 457Erlotinib Hydrochloride 456Trastuzumab 448Methotrexate 437Lenalidomide 426Pemetrexed 419

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Interventional × Fingolimod Hydrochloride × Clear all
NCT03941743 2023-07-21

Fingolimod in Preventing Paclitaxel-Associated Neuropathy in Patients With Breast Cancer

Mayo Clinic

Phase 1 Completed
2 enrolled
Breast

Breast Neoplasms

NCT02939079 2019-05-14

Evaluating of the Effect of Fingolimod With Fish Oil on Relapsing-Remitting Multiple Sclerosis Patients

Isfahan University of Medical Sciences

Phase 2/3 Completed
50 enrolled 20 charts

Multiple Sclerosis

NCT02490930 2017-09-13

A Safety Study of Fingolimod With Radiation and Temozolomide in Newly Diagnosed High Grade Glioma

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase EARLY_PHASE1 Completed
5 enrolled
CNS

Astrocytoma, Glioblastoma, Lymphopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡